Robert F. Kennedy Jr., who endorsed President-elect Donald Trump after exiting the 2024 race, is advocating for sweeping changes within the Food and Drug Administration (FDA). In a recent interview, Kennedy suggested that some divisions, particularly the FDA’s nutrition department, “have to go” due to what he views as failures to protect public health.
Kennedy has long criticized government agencies, and his latest remarks focus on reform rather than outright elimination. “There are entire departments, like the nutrition department at the FDA … that have to go,” he said, emphasizing his belief that the agency isn’t fulfilling its mission. While he doesn’t advocate for abolishing the FDA entirely, Kennedy claims he could eliminate “corruption” within the agency.
BREAKING: Robert F. Kennedy Jr. says he intends to clear out entire departments of the FDA. pic.twitter.com/Ho10s5T6gU
— Leading Report (@LeadingReport) November 6, 2024
Following his endorsement of Trump in August, Kennedy’s future role in the Trump administration is a topic of widespread speculation. He recently shared that he had spoken with Trump about potential roles and was “developing a proposal.” This has fueled suggestions that Kennedy could join Trump’s cabinet, possibly as secretary of Health and Human Services (HHS) or in a role exempt from Senate confirmation.
Kennedy’s switch from a Democratic primary challenger to an independent candidate, and then to a Trump supporter, brought a unique blend of moderate and independent voters into Trump’s coalition. Many believe his support bolstered Trump’s appeal among disaffected Democrats, contributing to Trump’s decisive victory.
FDA’s war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals and anything…
— Robert F. Kennedy Jr (@RobertKennedyJr) October 25, 2024
If Kennedy is appointed to the Trump administration, his focus on reform may lead to significant shifts in health policy. His critical stance on FDA structure and efficiency echoes Trump’s platform of reducing government bureaucracy to improve agency accountability and effectiveness.
Should Donald Trump and Robert Kennedy Jr. completely dismantle the FDA? 🤔 pic.twitter.com/OMMrS0eEta
— Gain of Fauci (@DschlopesIsBack) November 7, 2024
Kennedy’s stance on the FDA and his potential role underscore a shared vision with Trump’s team for government reform. His approach to restructuring could become a defining feature of health policy changes under Trump, impacting how federal health agencies operate in the years ahead.
